EGFR and colorectal carcinoma: KRAS-mutated CRC cells are frequently resistant to anti-EGFR treatments, the protein expression level of the p-EGFR/EGFR in KRAS-wild (Caco-2) and KRAS-mutant CRC cell lines (Figure 2A).